Bayern Munich honorary president Uli Hoeness has questioned whether Jamal Musiala will recover his previous level after the Germany forward’s neurological illness. BBC Sport and Sportsnet report his doubts, which come as the 23-year-old returns to training following a separate hamstring injury sustained in September.
Musiala collapsed twice in four days during pre-season. According to BBC Sport, he was subsequently found to have a treatable “neurological dysfunction”. He has scored twice in four appearances across all competitions this season, but has not played for Bayern since the hamstring injury.
Speaking to Bavarian network BR24, Hoeness described the difficulty facing the player and club: “We are facing a dilemma in this case, as he is suffering from an illness that cannot simply be cured, but it can be controlled to a certain extent with the use of medication.” He also said Bayern would support Musiala, whose contract runs until 2030.
Hoeness’s comments are his assessment of Musiala’s prospects, rather than a medical prognosis. Former Bayern and Germany captain Lothar Matthaus offered a different interpretation of their purpose, suggesting the honorary president was trying to provoke a response from the forward.
“He’s needling him a little,” Matthaus told Sky90, in comments carried by BBC Sport. “It’s not just about wrapping him in cotton wool. He also has to battle against adversity sometimes.” Matthaus said that, in Musiala’s position, he would use the remarks as motivation to demonstrate he was back.
Musiala’s record explains the level under discussion. He joined Bayern in 2019 after coming through Chelsea’s academy and broke into the first team at 17. Across 235 Bayern appearances, he has contributed 71 goals and 38 assists, while sharing the Golden Boot at Euro 2024 with Germany.
His return to training is the immediate development. Hoeness has raised a much longer-term question, but the reporting offers no firm answer about Musiala’s eventual playing level.
Read BBC Sport’s report for the comments from Hoeness and Matthaus, and Sportsnet’s coverage of Hoeness’s assessment.